The blood kinetics of collagen degradation products after exercise load in human: an open-label trial - The blood kinetics of collagen degradation products after exercise load in human

ORTHOMEDICO Inc.0 个研究点目标入组 10 人开始时间: 2023年3月31日最近更新: 2024年5月27日

试验速览

暂无简介。

•1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who cannot conduct exercise load due to locomotorium injury or pain (discomfort) 5. Subjects who usually take collagen-health food 6. Subjects currently taking medications (including herbal medicines) 7. Subjects who suffer from COVID-19 8. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 9. Subjects who are judged as ineligible to participate in this study by the physician

发起方